Latest oppositions filed by Sanofi Pasteur

This table presents recent patent oppositions filed by Sanofi Pasteur against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP3583947Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates ThereofPFIZER INC.Jul 11, 2024
EP3246044Stable Formulations Of Neisseria Meningitidis Rlp2086 AntigensWYETH LLCSep 29, 2021
EP3096785Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses ThereofPFIZER INC.Jun 8, 2021
EP2976101Method Of TreatmentGLAXOSMITHKLINE BIOLOGICALS S.A.May 18, 2021
EP2411048Adjuvanting Meningococcal Factor H Binding ProteinGLAXOSMITHKLINE BIOLOGICALS SAFeb 5, 2021
EP2869843Complexes Of Cytomegalovirus ProteinsGLAXOSMITHKLINE BIOLOGICALS SAMay 7, 2020
EP2676679Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic CompositionsWYETH LLCOct 2, 2019
EP3017827Pneumococcal Polysaccharide Conjugate VaccineGLAXOSMITHKLINE BIOLOGICALS S.A.Aug 6, 2019
EP2918684Rapid Sterility MicroassayNOVARTIS AGOct 10, 2018
EP3106176Aluminium Compounds For Use In Therapeutics And VaccinesVALNEVA AUSTRIA GMBHJul 10, 2018

The following table provides an overview of the latest patents of Sanofi Pasteur that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3007724Jul 5, 2023Compositions And Methods Of Immunizing Against C. Difficile1
EP3679915Jun 1, 2022Flavivirus Vaccines2
EP2851087Apr 19, 2017Stabilization Of Vaccines By Lyophilization2